DIA
Drug Information Association Logo

Featured Speakers

Gerald J. Dal Pan, MD
Director, Office of Surveillance and Epidemiology, CDER
FDA, United States

Ellis Unger, MD
Deputy Director, Office of Drug Evaluation-I, OND, CDER
FDA, United States

Robert J. Temple, MD
Deputy Center Director for Clinical Science, CDER
FDA, United States

Tarek A Hammad, MD,PhD,MS
Deputy Director
FDA, United States

Linda J. Scarazzini, MD
Director of Division of Pharmacovigilance I, CDER
FDA, United States

Stella C.F. Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
EMA Risk Management Development and Scientific Lead
European Medicines Agency, European Union, United Kingdom

Marc Berthiaume, MD
Director, Marketed Pharmacologicals and Medical Devices Bureau, MHPD
Health Canada, Canada

Adalton G. Ribeiro
Pharmacovigilance Director
Health Surveillance Centre CVS-SES-SP, Brazil

Kazuhiko Mori
Chief Safety Officer
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
© 2014 DIA